(en Español) Safety Announcement [2-15-2012] The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals; in particular, the medical imaging community; about the planned return […]

Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary Safety Announcement [04-22-2011] The U.S. Food and Drug Administration (FDA) continues to evaluate the risk of […]

What is heartburn? Heartburn occurs when stomach contents flow back up into the esophagus—the muscular tube that carries food and liquids from the mouth to the […]

Summary Company Announcement Date: March 19, 2026 FDA Publish Date: March 20, 2026 Product Type: Drugs Reason for Announcement: Recall Reason Description Microbial Contamination Company Name: […]

Crestor is in a class of drugs called “statins.” Statins are prescription drugs used together with diet and exercise to reduce blood levels of low-density lipoprotein […]

Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas. Esta actualización presenta información adicional relacionada con un […]

Safety AnnouncementAdditional Information for PatientsAdditional Information for Healthcare ProfessionalsData Summary  Safety Announcement [8-24-2011] The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients […]

On March 20, 2026, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and dacarbazine (AVD) for adult and pediatric […]

The FDA has issued new information about this safety issue, see the FDA Drug Safety Communication issued on 4-10-2012. This update is in follow-up to the […]